Nuno Prego Ramos, co-founder and CEO of CellmAbs, will share the journey of CellmAbs, from it's early days starting with an initial technology from NOVA University to becoming a pioneering force in cancer therapy innovation.
In this talk, we will hear about the strategic decisions, challenges and breakthroughs that propelled the company to its selling the assets to the pharmaceutical giant, BioNTech.
We make countless decisions each hour, each minute. Most of these decisions are made without our active awareness and while they may be inconsequential to us, they can impact other people. For instance, when we choose a seat on the train next to people who look most similar to ourselves or how much eye contact we make (or don’t make).
For millennia, humans have “tripped” on psychedelic substances for spiritual growth, healing or recreational purposes. Today, the healthcare community has renewed interest in the potential of psychedelics for mental health.
In this Ar event, Tiago Quendera and Tatiana Silva, two neuroscience PhD students at the Champalimaud Centre for the Unknown, will take you through the ups and downs of the history of psychedelics and their use in research.
Alexandra Borges, MD Radiologist, AMA accredited fellowship in Neuroradiology at UCLA,
PhD student from “Programa de formação médica avançada” (PFMA) 2nd edition
Title:
MR based biomarkers of treatment response to anti-VEGF mAb and their genomic correlates in a mouse model of High-Grade-Gliomas (HGG)
Speaker:
David Redish
Title:
Mental time travel in rats and humans: remembering the past and planning for the future
Featuring:
Lars Chittka
Affiliation:
Chittka Lab, School of Biological & Chemical Sciences, Queen Mary University of London
Title:
Alternate realities: how insects perceive the world
Featuring:
Lars Chittka
Affiliation:
Chittka Lab, School of Biological & Chemical Sciences, Queen Mary University of London
Title:
Alternate realities: how insects perceive the world